Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.

@article{Igarashi2013CostefficacyCO,
  title={Cost-efficacy comparison of biological therapies for patients with moderate to severe psoriasis in Japan.},
  author={Atsuyuki Igarashi and Hiroyo Kuwabara and Kyle Fahrbach and Brad Schenkel},
  journal={The Journal of dermatological treatment},
  year={2013},
  volume={24 5},
  pages={351-5}
}
BACKGROUND Biological therapies have recently been introduced for patients with moderate to severe psoriasis in Japan. OBJECTIVES This research aims to assess the cost efficacy of adalimumab, infliximab and ustekinumab treatments for psoriasis in a Japanese environment. METHODS A mixed-treatment comparison was performed to estimate the comparative efficacy of biological therapies using Psoriasis Area and Severity Index (PASI) scores based on data from randomized, double-blind, controlled… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Similar Papers

Loading similar papers…